Question 1

What are the potential benefits of switching between the immediate-release and extended-release forms of lamotrigine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa clinical trial (NCT00264615). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this trial help me manage my epilepsy better?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa clinical trial (NCT00264615). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of when switching formulations?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa clinical trial (NCT00264615). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa clinical trial (NCT00264615). Contact the study team or your healthcare provider for specific answers.

What this study is about